Comparison of Nevirapine Plasma Concentrations between Lead-In and Steady-State Periods in Chinese HIV-Infected Patients

Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals

(2011) A. Schipani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India

(2011) S. Swaminathan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection

(2011) Jia Wang et al.   PLoS One

Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population

(2009) TW Mahungu et al.   HIV MEDICINE

Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach

(2008) J. Molto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

(2008) C. Wyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort

(2008) Taisheng Li et al.   PLoS One